PRESS RELEASE published on 02/23/2023 at 20:00, 3 years 8 months ago Abivax publishes a prospectus in the context of its capital increase
PRESS RELEASE published on 02/23/2023 at 20:00, 3 years 8 months ago Abivax annonce la mise à disposition d’un prospectus dans le cadre de son augmentation de capital
PRESS RELEASE published on 02/22/2023 at 18:05, 3 years 8 months ago Abivax announces successful oversubscribed EUR 130M cross-over financing at market price with top-tier US and European biotech investors
PRESS RELEASE published on 02/22/2023 at 18:05, 3 years 8 months ago Abivax annonce le succès d’un financement cross-over sursouscrit de 130 millions d’euros au prix du marché, par des investisseurs américains et européens de premier plan
PRESS RELEASE published on 02/17/2023 at 08:00, 3 years 8 months ago Abivax appoints Dr. Sheldon Sloan, M.D., as Chief Medical Officer
PRESS RELEASE published on 02/17/2023 at 08:00, 3 years 8 months ago Abivax: Le Dr. Sheldon Sloan, M.D., est nommé Directeur Médical d’Abivax
PRESS RELEASE published on 02/14/2023 at 18:00, 3 years 8 months ago Abivax to present blood and rectal tissue data from UC patients treated with obefazimod at the 18th Congress of ECCO
PRESS RELEASE published on 02/14/2023 at 18:00, 3 years 8 months ago Abivax présentera lors du 18ème Congrès de l’ECCO des données issues d’échantillons sanguins et de biopsies rectales de patients atteints de RCH et traités avec obefazimod
PRESS RELEASE published on 01/31/2023 at 18:00, 3 years 9 months ago ABIVAX: NOTICE TO HOLDERS OF BONDS CONVERTIBLE AND/OR EXCHANGEABLE INTO NEW AND/OR EXISTING SHARES (OCEANES) WITH A NOMINAL VALUE OF EUR 24,999,975.99
PRESS RELEASE published on 01/31/2023 at 18:00, 3 years 9 months ago ABIVAX: AVIS AUX PORTEURS D’OBLIGATIONS CONVERTIBLES/ECHANGEABLES EN ACTIONS NOUVELLES ET/OU EXISTANTES (OCEANES) D’UN MONTANT NOMINAL DE 24 999 975,99 EUROS
Published on 11/05/2026 at 23:20, 32 minutes ago Health Canada Authorizes Moderna's mRNA Influenza and Combination Influenza and COVID-19 Vaccines
Published on 11/05/2026 at 22:05, 1 hour 47 minutes ago Innodata Reports Record Third Quarter 2026 Results
Published on 11/05/2026 at 22:01, 1 hour 51 minutes ago Unusual Machines Third Quarter 2026 Shareholder Letter
Published on 11/05/2026 at 15:20, 8 hours 32 minutes ago MicroVision and LAKE FUSION Technologies Sign Multi-Year Strategic Partnership Agreement for IRIS(TM) Lidar Sensors
Published on 11/05/2026 at 14:31, 9 hours 21 minutes ago First Breach Close-Quarters Strike (CQS) Drone Successfully Completes Full Mission Profile
Published on 11/05/2026 at 22:05, 1 hour 47 minutes ago Quantinuum Reports Third Quarter 2026 Results and Raises Full-Year Revenue Outlook
Published on 11/05/2026 at 20:38, 3 hours 13 minutes ago freenet uses funds from Ceconomy sale for waipu.tv acquisition and share buyback
Published on 11/05/2026 at 20:37, 3 hours 15 minutes ago EQS-Adhoc: freenet AG decides on share buyback programme for up to EUR 75 million
Published on 11/05/2026 at 19:45, 4 hours 6 minutes ago Stabilus SE fulfills forecast for fiscal 2026 and adjusts 2030 medium-term targets
Published on 11/05/2026 at 19:41, 4 hours 11 minutes ago EQS-Adhoc: Stabilus SE – Around €67 million in non-cash impairments reduce EBIT for FY2026; Preliminary Q4 FY2026 figures: Revenue and adjusted EBIT exceed market expectations, while adjusted free cash flow fall
Published on 11/05/2026 at 18:21, 5 hours 30 minutes ago Capital et droits de vote au 31 octobre 2026
Published on 11/05/2026 at 18:21, 5 hours 30 minutes ago Total number of voting rights and shares making up the share capital at October 31, 2026
